Finding that the skin of people with scleroderma makes a unique sugar, GlycoNet researcher Lisa Willis is developing a way to better identify those at high risk of disease progression.
Catégorie : Points saillants de la recherche
Glycoengineering provides insight into new cancer immunotherapies
By remodelling sugars on cell surfaces, GlycoNet researchers aim to map the linkages between proteins in the immune system and sugars on cancer cells
Redefining compatibility in organ transplantation
Applying a glycomics lens to the problem of organ donor-recipient compatibility, GlycoNet researcher Dr. Lori West is advancing the field of organ transplantation.
The secret to healthy aging
It’s all about monitoring sugar – but not in the way you may think
Op-ed: Glycomics research supports a cure for Type 2 diabetes from plants
GlycoNet scientists at UBC have found a plant compound that helps control blood sugar levels in people with Type 2 diabetes.
Carbohydrate research in animal health supports Canadian economy
GlycoNet scientist Mariela Segura is developing glycomics-based solutions to improve livestock health.
BioLab Business Magazine profile: GlycoNet facilitating glycomics research collaboration and innovation
A network serving the field of glycomics research provides a platform for connections and funding
A new research chair for dementia-causing diseases in children
Thanks to a large donation and the work of GlycoNet researcher and UdeM biochemist Alexey Pshezhetsky, the Elisa Linton Research Chair in Lysosomal Diseases will help treat Sanfilippo disease and similar genetic syndromes.
Tiny antibodies could help treat an aggressive type of breast cancer
GlycoNet researchers have developed specialized nanobodies that could enable the immune system to fight triple-negative breast cancer more effectively.
Nobel Prize in Chemistry shines light on glycomics
Congratulations to Drs. Carolyn Bertozzi and Morten Meldal whose groundbreaking work has opened doors in glycomics innovation.